http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02088752-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2a0157e97117980eed3cfe955b94652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f7eca65b981de321d90d73a683dccd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0804bbf12ded2306df86b5b7fdb828f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-72 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 |
| filingDate | 2002-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c1312cc2d54edc12344a5c6c478000 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175ea0fffa87ce1e3d8565d1bbfb8f65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e44329591d3604629364a159952c10a9 |
| publicationDate | 2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02088752-A2 |
| titleOfInvention | Method for detecting activator or inhibitor compounds of receptors of the family of the insulin receptor using an isolated chimeric receptor |
| abstract | The invention concerns a method for detecting activator and inhibitor compounds of receptors of the family of the insulin receptor by means of an isolated chimeric receptor, comprising a first alpha beta heterodimer, associated with a first response element and a second alpha beta heterodimer associated with a second response element different from the first, said first response element being capable of acting on the second response element when the two are brought close together. The invention also concerns such an isolated chimeric receptor, compositions containing it, and fusion cDNA's, expression vectors comprising said cDNA's and cells genetically modified by transfection of said expression vectors for expressing said chimeric receptor in a cell. The invention further concerns the use of the activator and inhibitor compounds of the family of the insulin receptor capable of binding with said isolated chimeric receptor for preparing a medicine designed for the treatment of human and/or animal pathologies or a medicine designed for tissue regeneration or still for preparing growth factors for cell culture. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8062886-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7217796-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7326567-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7811562-B2 |
| priorityDate | 2001-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.